Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access

Last updated: August 29, 2024
Sponsor: Memorial Healthcare System
Overall Status: Completed

Phase

N/A

Condition

Coronary Artery Disease

Vascular Diseases

Heart Disease

Treatment

Quikclot Radial (QC) Pad

Clinical Study ID

NCT03535597
QuikClot300
  • Ages > 18
  • All Genders

Study Summary

To evaluate the efficacy and safety of the QuikClot® Radial® pad on hemostasis after transradial access (TRA), compared to the standard of care TR Band®, to hopefully develop a safe and efficacious technique to achieve more rapid patent hemostasis after TRA, and improve patient care by optimizing radial hemostasis management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patients undergoing cardiac catheterization (CC) and/or percutaneous coronaryintervention (PCI) via the radial artery as part of their standard of care treatment

  2. Patients able and willing to give written informed consent

  3. Patient > 18 years of age

Exclusion

Exclusion Criteria:

  1. Patients presenting with acute ST-segment elevation myocardial infarction (STEMI)

  2. Oral anticoagulation therapy as described below:

  3. If on a DOAC (direct-acting oral anticoagulants - ie dabigatran, rivaroxaban,apixaban, edoxaban), patients will be excluded if DOAC taken within 48 hoursand eGFR > 30 ml/min or DOAC taken within 72 hours and eGFR < 30 ml/min.

  4. If the patient is on warfarin, excluded if INR > 1.5

  5. Liver Failure

  6. Life-threatening illness that the patient would not be expected to live more than 6months post-procedure

  7. Major unanticipated event in the cardiac cath lab (i.e. cardiac arrest) of analready consented patient, but before randomization, where the operator believesparticipation in this trial is now inappropriate.

  8. Thrombocytopenia, with a platelet count of < 75,000.

Study Design

Total Participants: 355
Treatment Group(s): 1
Primary Treatment: Quikclot Radial (QC) Pad
Phase:
Study Start date:
August 01, 2018
Estimated Completion Date:
December 28, 2022

Study Description

The QuikClot® Radial® (QC) pad will be applied over the radial artery access site covered with either a Coban™ bandage or a Tegaderm™ dressing after TRA. Firm manual compression will then be applied over the QC pad after the sheath is removed for 5 minutes. The Coban™ cohort will then have the Coban™ bandage removed after an additional 25 minutes, then be covered with a Tegaderm™ dressing. The Tegaderm™ only cohort will be closely observed for 25 minutes after release of manual pressure. Both cohorts will remove the Tegaderm™ dressing the following morning.

Consented subjects will be randomly assigned in the cardiac cath lab upon completion of their procedure into one of the following arms:

Arm 1 - Standard of Care with a TR Band®

Arm 2 - QC pad combined with a Coban™ bandage

Arm 3 - QC pad combined with a Tegaderm™ dressing. This arm was stopped after the enrollment of 73 patients and replaced by the QC/TR Band® arm

Arm 4- QC pad was applied on the radial arterial access site with 30 minutes of compression under a TR Band® inflated with 8-10 mL of air. Then the TR Band® was removed, leaving the QC pad covered with a Tegaderm™ dressing.

Connect with a study center

  • Memorial Healthcare System

    Hollywood, Florida 33021
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.